Status:
COMPLETED
Minimum Dose CT Post Lung Biopsy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Lung Cancer
Eligibility:
All Genders
16+ years
Phase:
PHASE1
Brief Summary
The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy
Detailed Description
Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax
Eligibility Criteria
Inclusion
- All Patients having a lung biopsy
Exclusion
- None
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00188162
Start Date
January 1 2004
End Date
September 1 2005
Last Update
April 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada